Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis (Q34647371)

3 August 2017

1 reference

title

Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis (English)

1 reference

3 August 2017

0 references

0 references

Valerio Iebba

3

0 references

Serena Schippa

object named as

Serena Schippa

5

0 references

Ulrich Thalheimer

object named as

Ulrich Thalheimer

7

0 references

Manuela Merli

object named as

Manuela Merli

6

0 references

author name string

Valerio Giannelli

1

1 reference

3 August 2017

Vincenza Di Gregorio

2

1 reference

3 August 2017

Michela Giusto

4

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 December 2014

1 reference

World Journal of Gastroenterology

3 August 2017

1 reference

3 August 2017

20

1 reference

3 August 2017

45

1 reference

3 August 2017

16795-16810

1 reference

The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Immune dysfunction in cirrhosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Gut microbiota and liver disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Interactions between the intestinal microbiome and liver diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Altered profile of human gut microbiome is associated with cirrhosis and its complications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Microbiome composition by pyrosequencing in mesenteric lymph nodes of rats with CCl4-induced cirrhosis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Metagenome and metabolism: the tissue microbiota hypothesis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Pathological bacterial translocation in liver cirrhosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Analyses of the stability and core taxonomic memberships of the human microbiome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Gut microbiota and hepatic encephalopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

The role of intestinal microbiota and the immune system.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Antibiotics for the treatment of hepatic encephalopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Modulation of the fecal bile acid profile by gut microbiota in cirrhosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Systemic inflammation and ammonia in hepatic encephalopathy.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

The gut microbiota and the liver. Pathophysiological and clinical implications.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Halomonas johnsoniae: review of a medically underappreciated genus of growing human importance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Linkage of gut microbiome with cognition in hepatic encephalopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Enterotypes of the human gut microbiome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Clinical significance of Propionibacterium acnes recovered from blood cultures: analysis of 524 episodes.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Current views of toll-like receptor signaling pathways

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Sterile inflammation: sensing and reacting to damage

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Gut microbiota in health and disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Rifaximin treatment in hepatic encephalopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Pattern recognition receptors and inflammation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

The liver as a lymphoid organ

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Analysis of bacterial bowel communities of IBD patients: what has it revealed?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Microbial influences in inflammatory bowel diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Pathophysiology of increased intestinal permeability in obstructive jaundice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

TLR4 enhances TGF-beta signaling and hepatic fibrosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Use and abuse of hydrogen breath tests

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

The interaction between bacteria and bile.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Host-bacterial mutualism in the human intestine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Infection, coagulation, and variceal bleeding in cirrhosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Bacterial translocation (BT) in cirrhosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Pathogenic Escherichia coli

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Relationship between cecal population levels of indigenous bacteria and translocation to the mesenteric lymph nodes.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Role of the liver in controlling the immunogenicity of commensal bacteria in the gut.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Translocation of Certain Indigenous Bacteria from the Gastrointestinal Tract to the Mesenteric Lymph Nodes and Other Organs in a Gnotobiotic Mouse Model

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258550

Characterization of fecal microbial communities in patients with liver cirrhosis.

7 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Autonomic neuropathy may be associated with delayed orocaecal transit time in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Intestinal permeability in cirrhotic patients with and without ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Bacterial translocation after cirrhotic liver resection: a clinical investigation of 181 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Rifaximin treatment in hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Alcohol-induced free radicals in mice: direct toxicants or signaling molecules?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Probiotic yogurt for the treatment of minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Bacterial translocation of enteric organisms in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I45.16795

Effect of Lactitol and Lactulose Administration on the Fecal Flora in Cirrhotic Patients

21 January 2018

1 reference

12 December 2020

Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites

1 reference

12 December 2020

Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites

1 reference

12 December 2020

Small bowel bacterial overgrowth in patients with alcoholic cirrhosis

1 reference

12 December 2020

Large-scale survey of gut microbiota associated with MHE Via 16S rRNA-based pyrosequencing

1 reference

12 December 2020

Natural history of autonomic neuropathy in chronic liver disease

1 reference

12 December 2020

Gastrointestinal dysfunction in liver disease and portal hypertension. Gut-liver interactions revisited

1 reference

12 December 2020

New perspectives on the role of the intestinal flora in health and disease

1 reference

12 December 2020

The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances

1 reference

12 December 2020

The bacterial content of the small intestine in normal and cirrhotic subjects: relation to methionine toxicity

1 reference

12 December 2020

Translocation of bacterial DNA from Gram-positive microorganisms is associated with a species-specific inflammatory response in serum and ascitic fluid of patients with cirrhosis

1 reference

12 December 2020

Cirrhotic Patients Are at Risk for Health Care–Associated Bacterial Infections

1 reference

12 December 2020

Antibiotics prevent liver injury in rats following long-term exposure to ethanol

1 reference

12 December 2020

Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis

1 reference

12 December 2020

Bacterial translocation from the gastrointestinal tract

1 reference

12 December 2020

Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis

1 reference

12 December 2020

Gut microbiome and intestinal barrier failure--the "Achilles heel" in hepatology?

1 reference

12 December 2020

Changes of gut bacteria and immune parameters in liver transplant recipients

1 reference

12 December 2020

Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites

1 reference

12 December 2020

10.3748/WJG.V20.I45.16795

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference